NASDAQ:IFRX - Inflarx Stock Price, News & Analysis

$3.07
+0.05 (+1.66 %)
(As of 09/16/2019 12:16 PM ET)
Today's Range
$3.03
Now: $3.07
$3.08
50-Day Range
$2.52
MA: $2.81
$3.06
52-Week Range
$2.45
Now: $3.07
$53.10
Volume810 shs
Average Volume563,869 shs
Market Capitalization$79.70 million
P/E RatioN/A
Dividend YieldN/A
Beta-1.49
InflaRx N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing inhibitors using C5a technology primarily in the United States and Europe. Its C5a is an inflammatory mediator involved in the enhancement of a variety of autoimmune and other inflammatory diseases. The company's lead product candidate is IFX-1, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that is in the Phase IIb clinical trial for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; to treat ANCA-associated vasculitis, a rare and life-threatening autoimmune disease; and for the treatment of other chronic/autoimmune diseases. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:IFRX
CUSIPN/A
CIKN/A
Phone49-36-4150-8180

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$7.64 per share

Profitability

Net Income$-35,210,000.00

Miscellaneous

Employees36
Market Cap$79.70 million
Next Earnings Date11/20/2019 (Estimated)
OptionableNot Optionable

Receive IFRX News and Ratings via Email

Sign-up to receive the latest news and ratings for IFRX and its competitors with MarketBeat's FREE daily newsletter.


Inflarx (NASDAQ:IFRX) Frequently Asked Questions

What is Inflarx's stock symbol?

Inflarx trades on the NASDAQ under the ticker symbol "IFRX."

How were Inflarx's earnings last quarter?

Inflarx NV (NASDAQ:IFRX) posted its earnings results on Wednesday, August, 14th. The company reported ($0.66) EPS for the quarter, missing the Zacks' consensus estimate of ($0.55) by $0.11. View Inflarx's Earnings History.

When is Inflarx's next earnings date?

Inflarx is scheduled to release their next quarterly earnings announcement on Wednesday, November 20th 2019. View Earnings Estimates for Inflarx.

What price target have analysts set for IFRX?

9 Wall Street analysts have issued 1 year price targets for Inflarx's stock. Their forecasts range from $5.00 to $47.00. On average, they anticipate Inflarx's share price to reach $17.4286 in the next year. This suggests a possible upside of 467.7% from the stock's current price. View Analyst Price Targets for Inflarx.

What is the consensus analysts' recommendation for Inflarx?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inflarx in the last year. There are currently 2 sell ratings and 7 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Inflarx.

Has Inflarx been receiving favorable news coverage?

Media coverage about IFRX stock has trended somewhat positive this week, InfoTrie reports. The research group scores the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Inflarx earned a media sentiment score of 0.9 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Inflarx.

Are investors shorting Inflarx?

Inflarx saw a increase in short interest in August. As of August 31st, there was short interest totalling 1,789,700 shares, an increase of 14.1% from the July 31st total of 1,569,000 shares. Based on an average daily volume of 1,910,000 shares, the days-to-cover ratio is currently 0.9 days. Currently, 10.3% of the shares of the stock are short sold. View Inflarx's Current Options Chain.

Who are some of Inflarx's key competitors?

What other stocks do shareholders of Inflarx own?

Who are Inflarx's key executives?

Inflarx's management team includes the folowing people:
  • Dr. Niels C. Riedemann M.D., Ph.D., Co-Founder, CEO & Exec. Director (Age 47)
  • Prof. Renfeng Guo, Co-Founder, Chief Scientific Officer & Exec. Director (Age 49)
  • Mr. Arnd Christ, Chief Financial Officer (Age 53)
  • Mr. Jason M. Marks J.D., Chief Legal Officer, Gen. Counsel & Corp. Sec. (Age 43)
  • Mr. Jordan Silverstein, Head of Corp. Devel. & Strategy

When did Inflarx IPO?

(IFRX) raised $100 million in an initial public offering on Wednesday, November 8th 2017. The company issued 6,700,000 shares at $14.00-$16.00 per share. J.P. Morgan, Leerink Partners and BMO Capital Markets served as the underwriters for the IPO.

Who are Inflarx's major shareholders?

Inflarx's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Cormorant Asset Management LP (5.78%), Morgan Stanley (1.30%), FNY Investment Advisers LLC (1.08%), Acadian Asset Management LLC (0.54%), Citadel Advisors LLC (0.38%) and D. E. Shaw & Co. Inc. (0.33%).

Which institutional investors are selling Inflarx stock?

IFRX stock was sold by a variety of institutional investors in the last quarter, including Cormorant Asset Management LP and Bamco Inc. NY.

Which institutional investors are buying Inflarx stock?

IFRX stock was acquired by a variety of institutional investors in the last quarter, including FNY Investment Advisers LLC, Morgan Stanley, Acadian Asset Management LLC, Alpine Global Management LLC, Atria Investments LLC, Atria Investments LLC, A.R.T. Advisors LLC and D. E. Shaw & Co. Inc..

How do I buy shares of Inflarx?

Shares of IFRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Inflarx's stock price today?

One share of IFRX stock can currently be purchased for approximately $3.07.

How big of a company is Inflarx?

Inflarx has a market capitalization of $79.70 million. The company earns $-35,210,000.00 in net income (profit) each year or ($1.40) on an earnings per share basis. Inflarx employs 36 workers across the globe.View Additional Information About Inflarx.

What is Inflarx's official website?

The official website for Inflarx is http://www.inflarx.de/.

How can I contact Inflarx?

Inflarx's mailing address is WINZERLAER STR. 2, JENA 2M, 07745. The company can be reached via phone at 49-36-4150-8180.


MarketBeat Community Rating for Inflarx (NASDAQ IFRX)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  153 (Vote Outperform)
Underperform Votes:  188 (Vote Underperform)
Total Votes:  341
MarketBeat's community ratings are surveys of what our community members think about Inflarx and other stocks. Vote "Outperform" if you believe IFRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IFRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/16/2019 by MarketBeat.com Staff

Featured Article: Earnings Reports

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel